Drug-eluting stents: is it the beginning of the end for coronary artery bypass surgery?
Raja
Shahzad G
SG
Department of Cardiac Surgery, Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow G3 8SJ, Scotland. drrajashahzad@hotmail.com
D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000628:therapy*; D016503:Drug Delivery Systems; D004958:Estradiol / Q000008:administration & dosage; D000068338:Everolimus; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D015607:Stents / Q000009:adverse effects; D016559:Tacrolimus / Q000008:administration & dosage
D004958:Estradiol; D000068338:Everolimus; D017239:Paclitaxel; D020123:Sirolimus; D016559:Tacrolimus